Department of Pathology, Znojmo Hospital, Czech Republic.
Cytohisto s.r.o., Breclav, Czech Republic.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2021 Mar;165(1):69-79. doi: 10.5507/bp.2020.006. Epub 2020 Mar 9.
Endometriosis is an inflammatory condition that shares a number of similarities with malignant diseases, such as an abnormal morphology, migration along the nerve bundles and metastatic spread to lymph nodes and distant organs. Endometriotic lesions are associated with oestrogen and progesterone imbalance which seems to play a key role in the pathogenesis of endometriosis. The aim of this study was to compare the status of both oestrogen and progesterone receptors in tissue of deep infiltrating endometriosis, lymph node endometriosis and atypical ovarian endometriosis using immunohistochemical methods, as well as to investigate the relationship between endometriosis and protein p53.
A total of 40 cases with deep infiltrating endometriosis were included in our study. Based on histopathological analysis of resected specimens, the cases were divided into 2 groups: group 1 - lymph node endometriosis (cases with lymph node involvement; n=12) and group 2 - deep infiltrating endometriosis (cases without lymph node involvement; n=28). As a control group, eutopic endometrium of adenomyosis- and endometriosis-free women were used (n=16). Five cases of atypical ovarian endometriosis as well as descriptions of the nerve involvement in endometriosis were also included. Immunohistochemical staining with a total of 4 markers was performed - oestrogen and progesterone receptors (ER, PR), p53 and Ki-67 (proliferation index).
The immunophenotype of the cases in groups 1 and 2 and in the control group was virtually identical in the proliferative phase - strong nuclear ER and PR expression in more than 90% of endometrial glandular and stromal cells. In the early and mid secretory phase, ER expression only slightly decreased (80%) in endometrial glandular cells in group 2 and the control group, whereas in the late secretory phase, significant decrease of ER expression only in the control group was observed (15-50%; P<0.001). In group 2 and the control group, significant decrease of PR expression only in endometrial glandular cells was observed in the mid and late secretory phase (less than 15%; P<0.001). Differences in receptor content were found only in isolated cases in group 2. In group 1, no secretory changes were found. In all three groups, sporadic and weak nuclear p53 expression in less than 3% in both endometrial glandular and stromal cells was detected (regardless of the phase of the menstrual cycle). In atypical ovarian endometriosis, higher and strong p53 expression (on average 26%) and decrease in ER (on average 56%) and PR (less than 1%) expression was observed; compared to the control group and groups 1 and 2, the differences for all 3 markers were highly significant (P<0.001). In all groups, the proliferation index (Ki-67) reached the highest values in the proliferation phase and decreased during the cycle. However, in endometriotic tissue, it was widely variable in the individual phases of the cycle. Perineural spread of endometriosis with significant neural hypertrophy, hyperplasia and involvement of the ganglia of the autonomic nervous system was detected in 5 cases (12.5%). Conlusion. From a histological and immunohistochemical point of view, deep infiltrating endometriosis and lymph node endometriosis appear to represent the same entity. For the first time, a simple immunohistochemical panel with antibodies against ER, PR and p53 useful in diagnosing atypical endometriosis has been described. The marked endometriosis-associated neural changes (endometriotic neuropathy) could be one of the causes of impaired function of the affected organs after debulking surgery with macroscopic negative resection margins as well as pain symptomatology in macroscopic inapparent endometriotic lesions.
子宫内膜异位症是一种炎症性疾病,与恶性疾病有许多相似之处,例如异常形态、沿神经束迁移和转移到淋巴结和远处器官。子宫内膜异位症病变与雌激素和孕激素失衡有关,这似乎在子宫内膜异位症的发病机制中起关键作用。本研究旨在通过免疫组织化学方法比较深部浸润性子宫内膜异位症、淋巴结子宫内膜异位症和非典型卵巢子宫内膜异位症组织中雌激素和孕激素受体的状态,并研究子宫内膜异位症与蛋白 p53 的关系。
本研究共纳入 40 例深部浸润性子宫内膜异位症患者。根据切除标本的组织学分析,将病例分为 2 组:第 1 组 - 淋巴结子宫内膜异位症(有淋巴结受累的病例;n=12)和第 2 组 - 深部浸润性子宫内膜异位症(无淋巴结受累的病例;n=28)。作为对照组,使用无腺肌病和子宫内膜异位症的妇女的在位子宫内膜(n=16)。还包括 5 例非典型卵巢子宫内膜异位症以及子宫内膜异位症中神经受累的描述。使用总共 4 种标记物进行免疫组织化学染色 - 雌激素和孕激素受体(ER、PR)、p53 和 Ki-67(增殖指数)。
第 1 组和第 2 组以及对照组的病例在增殖期的免疫表型几乎相同 - 子宫内膜腺和基质细胞中超过 90%的 ER 和 PR 表达呈强核。在早、中分泌期,第 2 组和对照组的子宫内膜腺细胞中 ER 表达仅略有下降(80%),而在晚分泌期,仅在对照组中观察到 ER 表达显著下降(15-50%;P<0.001)。在第 2 组和对照组中,仅在中、晚期分泌期观察到 PR 表达在子宫内膜腺细胞中显著下降(<15%;P<0.001)。在第 2 组中仅在个别病例中发现受体含量差异。在第 1 组中未发现分泌变化。在所有三组中,在子宫内膜腺和基质细胞中均检测到不到 3%的散在和弱核 p53 表达(无论月经周期如何)。在非典型卵巢子宫内膜异位症中,观察到更高和强的 p53 表达(平均 26%)和 ER(平均 56%)和 PR(<1%)表达降低;与对照组和第 1 组和第 2 组相比,所有 3 种标志物的差异均具有高度显著性(P<0.001)。在所有组中,增殖指数(Ki-67)在增殖期达到最高值,并在周期中降低。然而,在子宫内膜异位症组织中,它在各个周期阶段变化很大。在 5 例(12.5%)中检测到子宫内膜异位症的神经周围扩散,伴有明显的神经肥大、增生和自主神经系统神经节的参与。结论。从组织学和免疫组织化学的角度来看,深部浸润性子宫内膜异位症和淋巴结子宫内膜异位症似乎代表同一实体。首次描述了一种简单的免疫组织化学试剂盒,该试剂盒使用针对 ER、PR 和 p53 的抗体,可用于诊断非典型子宫内膜异位症。明显的与子宫内膜异位症相关的神经变化(子宫内膜异位症性神经病)可能是在宏观上无明显子宫内膜异位病变的情况下,在宏观上无残留的去瘤手术切除后,受累器官功能受损以及疼痛症状的原因之一。